Financial Results for the Third Quarter of Fiscal Year Ending March 31, 2012
January 30, 2012
Exchange where listed: TSE

Name of listed company: TERUMO CORPORATION(URL http://www.terumo.com/): 4543: Yutaro Shintaku, President and Representative Director: Tetsuya Kumei, General Manager, Corporate Communication Dept.
: +81 / 3 -6742 -8551

Company code number
Representative:
Please address all communications toPhone

1. Consolidated financial highlights for the interim period ended December 2011
(From April 1, 2011 to December 31, 2011)(1) Consolidated financial results(Note: The amounts shown below ignore values of less than a million yen)

Net sales

Operating income(Millions of yen)

(Notes) Comprehensive income:(Millions of yen)%

288,914244,241

Nine months ended December, 2011
Nine months ended December, 2010

December 2011: 376million yen (-97.2%)(Millions of yen)

46,31942,8953.7(3.8)

Net income%(Millions of yen)

21,962
27,4828.0(14.8)%(20.1)(13.7)

December 2010: 13,382million yen (−%)
Net income per share,
fully diluted

Net income per share
(Yen)

(Yen)

115.67144.73Nine months ended December, 2011
Nine months ended December, 2010%

49,875
48,10018.3
2.2

Ordinary income−−(Note) Percentage represents increase (decrease) from the corresponding period in the prior fiscal year.

(2) Consolidated financial position(Note: The amounts shown below ignore values of less than a million yen)

Total assets

Net assets

Equity ratio

Net assets per share(Millions of yen)

(Millions of yen)%(Yen)

657,513420,037

329,179
335,45650.0
79.8

1,732.47
1,765.32

As at December 31, 2011
As at March 31, 2011

(Note) Shareholders' equity : December 31, 2011: 328,960 million yen, March 31, 2011: 335,202 million yen.

2. Dividends
Cash dividends per share
4th quarter

1st quarter 2nd quarter 3rd quarter

Year ended March 31, 2011
Year ending March 31, 2012
Year ending March 31, 2012 (forecast)

total(Yen)

(Yen)

(Yen)

(Yen)

(Yen)

−
−

16.00
17.00

−
−

18.00

34.00

17.00

34.00

(Note) Revise of dividends forecast : None

3. Consolidated forecast for the year ending March 2012 (From April 1, 2011 to March 31, 2012)
Operating income

Net salesYear ending March, 2012

Net income
per share

Net income

Ordinary income(Millions of yen)%

(Millions of yen)%

(Millions of yen)%

(Millions of yen)%

383,000

16.7

62,600(0.0)

57,0000.2

26,000(19.6)(Yen)

136.93

1. Forecast for fiscal year ending March, 2012 which was announced on October 27, 2011 has been revised.
(Assumed exchange rate for fiscal year ending March, 2012: USD1=JPY77, EUR1=JPY108)
The above mentioned ratio of consolidated financial results and consolidated forecast are growth againt previous year.
2. Among the information that Terumo discloses, forecasts of financial performance on future projections contain potential risks and uncertainty since theseare forecasts on projections made by Terumo based on limited information available at the moment of disclosure. Accordingly, it should be noted that actualresults may differ from those forecasts on projections due to various factors. Factors affecting to actual results include, but are not limited to, changes ineconomic conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition.

14. Consolidated Financial Statements(1) Consolidated Balance Sheets(Millions of yen)
As at March 31, 2011
Amount(Assets)
I Current assets%

236,51056.3%

As at December 31,
2011
Amount241,581

Cash and deposits

83,79473,970Notes and accounts receivable-trade

76,48087,917

Inventries

57,67365,913

Deferred tax assets

7,797

8,203

Derivatives

6,084

63

Other

5,406

6,563

Allowance for doubtful accounts(726)(1,051)%
36.7%

II Noncurrent assets

183,52743.7%

415,932

63.3%

1. Property, plant and equipment

113,05926.9%

126,871

19.3%

Buildings and structures45,052

46,252

Machinery, equipment and vehicles

29,86135,942

Land

20,227

21,194950

1,138

Construction in progress

10,442

14,972

Other

6,524

7,372

Lease assets

2. Intangible assets

26,728Goodwill
Customer relationship
Other

6.4%

258,518

20,191

134,072−

80,487

6,537

43,957

3. Investments and other assets

43,739Investment securities

28,895

17,118Deferred tax assets

8,136

7,537

Other

6,706

5,886

Total assets

420,0372

10.4%

100.0%

30,542

657,513

39.3%

4.7%

100.0%

(Millions of yen)
As at March 31, 2011Amount(Liabilities)
I Current liabilities%

78,846

Notes and accounts payable-trade18.8%

As at December 31,
2011
Amount%278,983

30,711

31,346−200,000

294

364

Income taxes payable

6,297

2,086

Deferred tax liabilities

123

30

Provision for bonuses

Short-term loans payable
Lease obligations

5,001

2,731

Provision for directors' bonuses

145

108

Provision for loss on disaster

351

2

5,749

7,106

560

840

Notes and accounts payable - facilities
Asset retirement obligations
Other

29,61134,366

II Noncurrent liabilities

5,734

Lease obligations

636

765

Deferred tax liabilities

378

42,700

1,082
586

1,083
202

991

152

2,060

4,444

Provision for retirement benefits
Provision for directors' retirement benefits
Asset retirement obligations
Other

Total liabilities(Net assets)
I Shareholders' equity

1.3%

49,34920.1%

328,33350.0%

363,832

86.6%

379,14257.6%

38,716

38,716

Capital surplus

59,03052,103Retained earnings

342,965

288,324

Treasury stock(76,879)(2)(28,630)(6.8%)(50,181)

Valuation difference on available-for-sale securities(1,919)(2,906)

Deferred gains or losses on hedges

3,611

0

Foreign currency translation adjustment

III Minority interests
Total net assets
Total liabilities and net assets

37.5%

84,581

Capital stock

II Accumulated other comprehensive income

42.5%(7.6%)(30,322)254

0.1%(47,275)
219

0.0%

335,45679.9%

329,17950.0%

420,037

100.0%

657,513100.0%

(2) Consolidated Statements of Income(Millions of yen)

For nine months ended
December 31, 2010
Amount%For nine months ended
December 31, 2011
Amount%I Net sales
II Cost of sales
Gross profit
III Selling, general and administrative expenses

244,241100.0%

288,914100.0%

117,07747.9%

134,924

46.7%

Operating income
IV Non-operating income

127,16452.1%

153,989

53.3%

79,06432.4%

104,11436.0%

48,10019.7%

49,875

17.3%

1,515

0.5%

5,071

1.8%

46,319

16.0%

397

0.2%

Interest income

194

225

Dividends income

379

289

Royalty income

108

115

Equity in earnings of affiliates

6967

Other368

1,121

0.5%

818

V Non-operating expenses
Interest expenses
Sales discounts
Foreign exchange losses

56536434
5,150

2,837

Loss on disposal of inventories

196

Other488

Ordinary income
VI Extraordinary income

446
788
6,326

2.6%

42,895

17.6%

462

Gain on sales of noncurrent assets
Reversal of allowance for doubtful accounts

81

130

Reversal of provision for loss on disaster−

156

Gain on contribution of securities to retirement
benefit trust

494−

Subsidy income

−

504

0.1%

227

VII Extraordinary expenses
Loss on disposal of noncurrent assets

303−

Loss on sales of investment securities
Loss on valuation of investment securities
Directors' retirement benefit

1915

Loss on sales of golf memberships−

Income before income taxes
Income taxes-current

13,313

Income taxes-deferred

2,208

Income before minority interests
Minority interests in income

Net income

475
1,562
7,754
−
338

0.1%

43,060

17.6%

5

9,396

3.3%

37,32012.9%

13,04915,521

6.3%

15,3195.3%

27,539
56

11.3%
0.0%

2,269

22,000
38

7.6%
0.0%

27,482

11.3%

21,962

7.6%

(3) Consolidated statement of comprehensive income(Millions of yen)

For nine months ended
December 31, 2010

For nine months ended
December 31, 2011

AmountAmount

I Income before minority interests
II Othercomprehensive
incomeValuationdifference on
available-for-salesecurities

27,539Valuation difference on available-for-sale securities
Deferred gains or losses on hedges
Foreign currency translation adjustments
Share of other comprehensive income of associates
accounted for using equity method(3,371)(986)−(3,611)(10,782)(17,026)(2)Comprehensive income

22,000(14,156)

0(21,624)

13,382376

13,362411

19(35)

Attributable to:Shareholders of Terumo CorporationMinority interests

55. Segment Information[Reportable Segments](1) The Third Quarter of Fiscal Year Ended March 31, 2011

(Millions of yen)
For nine months ended
December 31, 2010

GeneralHospitalbusiness

Cardiac &Vascularbusiness

Blood
Transfusionbusiness

Consumer
Healthcare
business

Subtotal

Adjustment

Total

Sales and operating income:Sales to customer

115,506

106,840

18,394

3,359

244,101139−−−−−−−

Sales total

115,506

106,840

18,394

3,359

244,101

139

244,241

Segment income (loss)

21,272
26,9492,256(895)
49,583(1,483)
48,1001. The (1,483) million yen adjustment to segment profit is the sum of the (786)Internal sales

Notes:

244,241

million yen for inventories and the (697) million yen for others.
2. Segment income (loss) is adjusted to be consistent with operating income shownon the quarterly consolidated income statement.
(2) The Third Quarter of Fiscal Year Ending March 31, 2012
For nine months ended
December 31, 2011
GeneralHospitalbusiness

Cardiac &Vascularbusiness

Blood
Managementbusiness

Consumer
Healthcare
business(Millions of yen)

Subtotal

Adjustment

Total

Sales and operating income:Sales to customer

113,528

118,672

53,226

3,486

288,914−

288,914

−

−

−−−−

−

Sales total

113,528

118,672

53,226

3,486

288,914−

288,914Segment income (loss)

22,127

24,9342,520

80

49,663

211

49,875Internal sales

Notes:

1. The 211 million yen adjustment to segment profit is the sum of the (866) million

yen for inventories and the 1,078 million yen for others.
2. Segment income (loss) is adjusted to be consistent with operating income shownon the quarterly consolidated income statement.
3. From the first quarter of fiscal year ending March 31, 2012, the name ofreportable segment has been changed from Blood Transfusion business to BloodManagement business.
4. Depreciation of tangible fixed assets of the Company and its domestic

consolidated subsidiaries had been computed by declining-balance method , buteffective from this fiscal year, straight-line method has been applied to all
tangible fixed assets. Consequently, segment income increased by 1,770 million
yen in the General Hospital business, 891 million yen in the Cardiac &Vascular business, 286 million yen in the Blood Management business, and 23million yen in the Consumer Healthcare business from the amounts that would
have been posted under the previous accounting method.
5. As a result of M&A in the first quarter of the fiscal year ending March 31, 2012,

CaridianBCT has been included in the scope of consolidation.
The assets of the reportable segment, Blood Management business, as atDecember 31, 2011 increased 257,755 million yen than that as at March 31,2011.

6

(Note) Main products belonging to each business segment

Business segments

Main products

General Hospital business
Disposable medical devices
and Medical electronicsSyringes, Needles, Blood collection tubes, Home parenteral nutrition system,
Solution sets, I.V.catheters, Infusion pumps, Syringe pumps, Home oxygen therapysystem, etc.

Pharmaceuticals

I.V.solutions, Nutritious food, Prefilled syringes, CAPD systems, etc.

Diabetes care products

Blood glucose monitoring systems

Cardiac and Vascular business
Interventional systems

Angiographic catheters, PTCA balloon catheters, Coronary stents, Neuro interventionalcoils, etc.

Cardiovascular systems

Oxygenerators, Cardio-pulmonary bypass system, LVA system, etc.

Vascular grafts

Artificial vascular grafts, Stent graftsBlood Management business

Blood bags, Automated blood processing, Therapeutic aphaeresis, Cell therapy, etc.

Consumer Healthcare business

Digital thermometers, Blood pressure monitors, Blood glucose monitors (OTC), etc.

(Supplemetary Information)[Geographic segments](1) The Third Quarter of Fiscal Year Ended March 31, 2011
For nine months ended
December 31, 2010
Japan

Overseas Total

EuropeAmericas(Millions of yen)

Asia and others

Total

Sales

133,897

110,343

40,07845,04024,970244,241

Operating income

30,647

17,452

7,339

5,332

4,683

48,100(2) The Third Quarter of Fiscal Year Ending March 31, 2012
For nine months ended
December 31, 2011
Japan

Overseas Total

EuropeAmericas(Millions of yen)

Asia and others

Total

Sales

141,899

147,014

41,39478,251

27,368288,914

Operating income

26,74823,126

6,956

11,265

4,904

49,875

7